Clinical Trial Update: Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on salusin-α for lipid abnormalities in hemodialysis patients, with the study conducted by Poznan University of Medical Sciences a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperlipidemia
• Metabolic Syndrome
• Type 2 Diabetes Mellitus

Drugs mentioned

• Salusin-alpha (salusin-α)

Snippet

Sponsor: Poznan University of Medical Sciences | Conditions: Renal Failure Chronic Requiring Hemodialysis, Metabolic Syndrome | Phase 4 | Status: COMPLETED